Turkey’s growing pharmaceutical sector becoming investor hotspot
Hurriyet / Ekonomist (Magazine) - Turkey’s growing pharmaceutical sector—6th in Europe and 14th in the world in size—has made it to the headlines of global business publications with last week’s acquisition of local generics manufacturer Mustafa Nevzat by US biotech giant Amgen. Although shadowed by the sum of the deal between Amgen and Mustafa Nevzat, reaching USD 700 million for 95.6 percent of shares, Turkey’s pharma sector has attracted a series of transactions by foreign drugmakers in the last 10 years seeking growth in a market that is experiencing a rapid expansion on the back of a high performing economy.
More:Balkans.com Business News : Turkey’s growing pharmaceutical sector becoming investor hotspot
